Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0000721748-13-000568
Filing Date
2013-08-28
Accepted
2013-08-28 17:20:31
Documents
10
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 andn10qa0828.htm 10-Q/A 50493
8 SECTION 1350 CERTIFICATION andnex32.htm EX-32 5028
9 RULE 13A-14(A)/15D-14(A) CERTIFICATION andnex311.htm EX-31.1 10579
10 RULE 13A-14(A)/15D-14(A) CERTIFICATION andnex312.htm EX-31.2 10080
  Complete submission text file 0000721748-13-000568.txt   2407294

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE FILE andn-20130630.xml EX-101.INS 155870
3 XBRL SCHEMA FILE andn-20130630.xsd EX-101.SCH 17723
4 XBRL CALCULATION FILE andn-20130630_cal.xml EX-101.CAL 25592
5 XBRL DEFINITION FILE andn-20130630_def.xml EX-101.DEF 32901
6 XBRL LABEL FILE andn-20130630_lab.xml EX-101.LAB 141902
7 XBRL PRESENTATION FILE andn-20130630_pre.xml EX-101.PRE 111267
Mailing Address 350 S. CENTER STREET SUITE 500 RENO NV 89501
Business Address 350 S. CENTER STREET SUITE 500 RENO NV 89501 775-333-5997
ANDAIN, INC. (Filer) CIK: 0001321502 (see all company filings)

EIN.: 202066406 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-51216 | Film No.: 131066748
SIC: 2834 Pharmaceutical Preparations